Literature DB >> 7923544

Design, content and financing of an essential national package of health services.

J L Bobadilla1, P Cowley, P Musgrove, H Saxenian.   

Abstract

A minimum package of public health and clinical interventions, which are highly cost-effective and deal with major sources of disease burden, could be provided in low-income countries for about US$ 12 per person per year, and in middle-income countries for about $22. Properly delivered, this package could eliminate 21% to 38% of the burden of premature mortality and disability in children under 15 years and 10-18% of the burden in adults. The cost would exceed what governments now spend on health in the poorest countries but would be easily affordable in middle-income countries. Governments should ensure that, at the least, poor populations have access to these services. Additional public expenditure should then go either to extending coverage to the non-poor or to expansion beyond the minimum collection of services to an essential national package of health care, including somewhat less cost-effective interventions against a larger number of diseases and conditions.

Entities:  

Keywords:  Cost Effectiveness; Delivery Of Health Care; Developing Countries; Economic Factors; Evaluation Indexes; Financial Activities; Financing, Government; Health; Health Services; National Health Services; Public Health; Quantitative Evaluation; Theoretical Studies

Mesh:

Year:  1994        PMID: 7923544      PMCID: PMC2486601     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  Effects of early-life conditions on adult mortality: a review.

Authors:  I T Elo; S H Preston
Journal:  Popul Index       Date:  1992

2.  Quantifying the burden of disease: the technical basis for disability-adjusted life years.

Authors:  C J Murray
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

3.  Selective primary health care: an interim strategy for disease control in developing countries.

Authors:  J A Walsh; K S Warren
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

  3 in total
  31 in total

Review 1.  The global burden of mental disorders.

Authors:  T B Ustün
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

2.  A reassessment of the cost-effectiveness of water and sanitation interventions in programmes for controlling childhood diarrhoea.

Authors:  R C Varley; J Tarvid; D N Chao
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

3.  Whose priorities count? Comparison of community-identified health problems and Burden-of-Disease-assessed health priorities in a district in Uganda.

Authors:  Lydia Kapiriri; Ole Frithjof Norheim
Journal:  Health Expect       Date:  2002-03       Impact factor: 3.377

4.  Valuing Stillbirths.

Authors:  John Phillips; Joseph Millum
Journal:  Bioethics       Date:  2014-11-14       Impact factor: 1.898

5.  Will private health insurance schemes subscriptions continue after the introduction of National Health Insurance in Uganda?

Authors:  C M Zikusooka; R L Kyomuhang; J N Orem; M Tumwine
Journal:  Afr Health Sci       Date:  2009-10       Impact factor: 0.927

Review 6.  Clarifying efficiency-equity tradeoffs through explicit criteria, with a focus on developing countries.

Authors:  Chris James; Guy Carrin; William Savedoff; Piya Hanvoravongchai
Journal:  Health Care Anal       Date:  2005-03

7.  DALYs: the age-weights on balance.

Authors:  J J Barendregt; L Bonneux; P J Van der Maas
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

8.  Assessing health needs in developing countries.

Authors:  J Wright; J Walley
Journal:  BMJ       Date:  1998-06-13

Review 9.  Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.

Authors:  Samuel D Shillcutt; Damian G Walker; Catherine A Goodman; Anne J Mills
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines.

Authors:  A T Newall; M Jit; R Hutubessy
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.